Anti-vascular endothelial growth factor (VEGF) drugs compared to laser photocoagulation for treatment of type 1 retinopathy of prematurity

Anti-vascular endothelial growth factor (VEGF) drugs compared to laser photocoagulation for treatment of type 1 retinopathy of prematurity

INTRODUCTION Retinopathy of prematurity (ROP) is a condition that affects preterm infants, being the second leading cause of childhood blindness worldwide. The most commonly used treatments are cryotherapy or laser photocoagulation, but over the last few years, anti-vascular endothelial growth fact...

Full description

Bibliographic Details
Main Authors: Raúl González C., Marcela Díaz C., Rodolfo Garretón C
Format: Article
Language:English
Published: Medwave Estudios Limitada 2022-01-01
Series:Medwave
Subjects:
retinopathy of prematurity (rop)
anti-vascular endothelial growth factor (anti-vegf)
laser coagulation
epistemonikos
grade.
Online Access:https://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/8507.act

Internet

https://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/8507.act

Similar Items